About AreteMedical

The startup develops digital therapeutic devices that utilize artificial intelligence and biomechanical modeling to enhance the management of chronic respiratory conditions. By reducing sensor costs, their technology enables healthcare providers to achieve better patient outcomes and improve health system efficiency.

```xml <problem> Managing chronic respiratory conditions like asthma and COPD often requires frequent and costly visits to specialist clinics for lung function testing. Existing diagnostic equipment is typically bulky, expensive, and confined to hospital settings, limiting accessibility for patients needing regular monitoring. This lack of convenient and affordable monitoring tools hinders proactive management and early intervention, leading to preventable hospitalizations and reduced quality of life. </problem> <solution> Arete Medical Technologies offers a portable, web-connected device called the Respicorder that enables comprehensive respiratory monitoring in the home. The Respicorder combines three essential breathing tests—spirometry, impulse oscillometry, and FeNO measurement—into a single, user-friendly device. By providing hospital-grade measurements at a fraction of the cost of traditional equipment, the Respicorder empowers patients and their healthcare teams to proactively manage lung conditions with precision and prevention. The device facilitates early detection of respiratory distress, personalized treatment adjustments, and reduced reliance on emergency care, ultimately improving patient outcomes and reducing healthcare costs. The Respicorder serves as the foundation for a digital hub, integrating data and facilitating communication between patients and their healthcare providers for optimized respiratory care. </solution> <features> - Combines spirometry, impulse oscillometry, and FeNO measurement in a single portable device - Web-connected for seamless data transfer and remote monitoring - Enables frequent and convenient at-home respiratory assessments - Provides hospital-grade measurements at a fraction of the cost of traditional equipment - Facilitates early detection of respiratory distress and personalized treatment adjustments - Supports a digital hub for integrated data management and communication between patients and healthcare providers </features> <target_audience> The primary target audience includes individuals with chronic respiratory conditions such as asthma and COPD, as well as healthcare providers seeking to improve patient outcomes and reduce healthcare costs through proactive and precision respiratory care. </target_audience> ```

What does AreteMedical do?

Where is AreteMedical located?

AreteMedical is based in Cambridge, United Kingdom.

When was AreteMedical founded?

AreteMedical was founded in 2017.

How much funding has AreteMedical raised?

AreteMedical has raised 280000.

Location

Cambridge, United Kingdom

Founded

2017

Funding

280000

Employees

1 employees

Major Investors

Central London Community Healthcare NHS Trust

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

AreteMedical

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

aretemedtech.com 1K+

Crunchbase

Founded 2017 – Cambridge, United Kingdom

Funding

Estimated Funding

$100K+

Major Investors

Central London Community Healthcare NHS Trust

Team (<5)

No team information available.

Company Description

Problem

Managing chronic respiratory conditions like asthma and COPD often requires frequent and costly visits to specialist clinics for lung function testing. Existing diagnostic equipment is typically bulky, expensive, and confined to hospital settings, limiting accessibility for patients needing regular monitoring. This lack of convenient and affordable monitoring tools hinders proactive management and early intervention, leading to preventable hospitalizations and reduced quality of life.

Solution

Arete Medical Technologies offers a portable, web-connected device called the Respicorder that enables comprehensive respiratory monitoring in the home. The Respicorder combines three essential breathing tests—spirometry, impulse oscillometry, and FeNO measurement—into a single, user-friendly device. By providing hospital-grade measurements at a fraction of the cost of traditional equipment, the Respicorder empowers patients and their healthcare teams to proactively manage lung conditions with precision and prevention. The device facilitates early detection of respiratory distress, personalized treatment adjustments, and reduced reliance on emergency care, ultimately improving patient outcomes and reducing healthcare costs. The Respicorder serves as the foundation for a digital hub, integrating data and facilitating communication between patients and their healthcare providers for optimized respiratory care.

Features

Combines spirometry, impulse oscillometry, and FeNO measurement in a single portable device

Web-connected for seamless data transfer and remote monitoring

Enables frequent and convenient at-home respiratory assessments

Provides hospital-grade measurements at a fraction of the cost of traditional equipment

Facilitates early detection of respiratory distress and personalized treatment adjustments

Supports a digital hub for integrated data management and communication between patients and healthcare providers

Target Audience

The primary target audience includes individuals with chronic respiratory conditions such as asthma and COPD, as well as healthcare providers seeking to improve patient outcomes and reduce healthcare costs through proactive and precision respiratory care.